FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16460511000001101: Ubidecarenone 30mg / Magnesium oxide 150mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57439901000001118 Ubidecarenone 30mg / Magnesium oxide 150mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57440001000001113 Ubidecarenone 30mg / Magnesium oxide 150mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Is a Magnesium oxide + Ubidecarenone true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Has specific active ingredient Magnesium oxide true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Has specific active ingredient Ubidecarenone true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Has active ingredient Magnesium oxide true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Has active ingredient Ubidecarenone true Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Coenzyme Q10 30mg + Magnesium 150mg tablets (Wassen International Ltd) Is a True Ubidecarenone 30mg / Magnesium oxide 150mg tablets Inferred relationship Existential restriction modifier
Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet Has VMP True Ubidecarenone 30mg / Magnesium oxide 150mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start